Talk:Talizumab

December 2006, merged from TX-901

this drug wouldn't just prevent small reactions of peanuts, it would work for whatever a particular person would be allergic to, peanuts allergies are just common67.171.69.23 17:37, 5 December 2006 (UTC)

greed reigns

Ran across a hopeful article on TNX-901 and it's positive effect -- some might even say "cure" -- on the plight of peanut allergy sufferers in an old Reader's Digest. Caught my eye because a friend has this highly dangerous allergy. Came on-line to see what the current status was and was horrified to learn that, once again, corporate greed outweighs human life. Essentially, two large drug companies reneged on an agreement with their third partner and blocked further development of a drug that was shown to prevent anaphylactic shock (affecting tens of thousands annually, killing hundreds in the process). Why? Because their management teams were afraid that this new drug _MIGHT_ compete with a drug they already had on the market that is NOT approved for this purpose by the FDA (it's an asthma drug); nor has it been shown to be effective for this condition. But it does costs four figures a month. We certainly wouldn't want to jeopardize that possible future cash flow to save a couple hundred people a year and prevent the suffering of thousands more, eh? 71.188.227.62 (talk) 06:37, 11 July 2012 (UTC)

POV

This is an article about an antibody, not a general treatise on greed. — Preceding unsigned comment added by 18.56.5.92 (talk) 21:56, 23 January 2013 (UTC)

A balanced view in its present form

The earlier opinions focus on the greed of giant pharmaceutical or biotech companies and their insensitivity to the desperate need of patients with severe allergy to peanut. The present form of TNX-901 provides many articles from major media publications to deal with the "greed" topic. The discussion in the TNX-901 article is rather balanced in its present form. — Preceding unsigned comment added by PeaceRock (talk • contribs) 01:36, 15 March 2013 (UTC)